Wordt geladen...
Smad4 promotes diabetic nephropathy by modulating glycolysis and OXPHOS
Diabetic nephropathy (DN) is the leading cause of end‐stage kidney disease. TGF‐β1/Smad3 signalling plays a major pathological role in DN; however, the contribution of Smad4 has not been examined. Smad4 depletion in the kidney using anti‐Smad4 locked nucleic acid halted progressive podocyte damage a...
Bewaard in:
| Gepubliceerd in: | EMBO Rep |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7001498/ https://ncbi.nlm.nih.gov/pubmed/31916354 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/embr.201948781 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|